Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Baranello (London, United Kingdom), L. Servais (Oxford, United Kingdom), R. Masson (Milan, Italy), M. Mazurkiewicz-Beldzinska (Gdansk, Poland), K. Rose (Sydney, Australia), D. Vlodavets (Moscow, Russian Federation), H. Xiong (Beijing, China), E. Zanoteli (São Paulo, Brazil), M. El-Khairi (Welwyn Garden City, United Kingdom), S. Fuerst-Recktenwald (Basel, Switzerland), M. Gerber (Basel, Switzerland), K. Gorni (Basel, Switzerland), H. Kletzl (Basel, Switzerland), R. Scalco (Basel, Switzerland), B. Darras (Boston, MA, United States of America). FIREFISH Part 2: Efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA). 1172

Member's Comments

No comment yet.

Related content which might interest you: Evaluating the respiratory health of children with spinal muscular atrophy (SMA) type 1 on Nusinersen Source: International Congress 2018 – Assessing pathophysiology in children Year: 2018 Respiratory pattern during sleep in infant and children with spinal muscular atrophy (SMA) type 1 and 2: comparison with healthy controls Source: Eur Respir J 2004; 24: Suppl. 48, 621s Year: 2004 Preventative NIV in spinal muscular atrophy (SMA) type I and II Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting Year: 2008 Spinal muscular amiotrophy (SMA) type 1 survival: Data from a tertiary center Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Nocturnal efficacy of servo-adaptative ventilation in patient with Type 1 myotonic dystrophy (MD1) Source: Annual Congress 2010 - Long-term noninvasive ventilation in the chronic patient: outcome and pathophysiology Year: 2010 Spontaneous breathing pattern in children with spinal muscle atrophy (SMA) Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects Year: 2015 Adaptation of children with spinal muscolar atrophy type 1 and 2 to non invasive ventilatory support Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011 Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference? Source: Eur Respir J 2001; 18: Suppl. 33, 88s Year: 2001 Alterations of thoraco-abdominal volumes in patients with spinal muscle atrophy (SMA) Source: Annual Congress 2013 –Respiratory physiology in health and disease Year: 2013 Glossopharyngeal breathing in children with spinal muscular atrophy type II Source: Annual Congress 2008 - Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients Year: 2008 Safety, pharmacodynamics (PD) and pharmacokinetics (PK) of darotropium (DARO) and vilanterol (VI) in healthy subjects: Two phase 1 studies Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Efficacy of non invasive ventilation for treatment of sleep disordered breathing in infant and children with spinal muscular atrophy types 1 and 2 Source: Eur Respir J 2006; 28: Suppl. 50, 118s Year: 2006 Spinal cord stimulation (SCS) to restore cough in spinal cord injury (SCI) subjects: Long-term follow-up Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014 Scoliosis and spinal fusion (SF) correlate with spirometry but not with breathing pattern at rest in Duchenne muscular dystrophy (DMD) Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects Year: 2015 Impact of chronic intermittent spinal cord stimulation (SCS) on airway pressure generation (P) for cough production in spinal cord injury (SCI) Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function Year: 2014 Respiratory Issues in patients with Spinal Muscular Atrophy (SMA) type 1, Treated with Disease-Modifying Therapy Source: Virtual Congress 2021 – Primary ciliary dyskinesia and tracheostomy Year: 2021 Overnight gas exchange and ventilatory support in spinal muscular atrophy type 2 patients after 12 months of nusinersen treatment Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment Year: 2020 Main outcomes in patients with amyotrophic lateral sclerosis (ALS) on mechanical ventilation (MV) undergoing a Pulmonary Rehabilitation (PR) program Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Effect of moderate hepatic impairment (MHI) on umeclidinium (UMEC) and vilanterol (VI) pharmacokinetics (PK) Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013